Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Equity Average (2016 - 2025)

Historic Equity Average for Firefly Neuroscience (AIFF) over the last 13 years, with Q3 2025 value amounting to $10.9 million.

  • Firefly Neuroscience's Equity Average rose 64528.82% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 64528.82%. This contributed to the annual value of -$133000.0 for FY2024, which is 8743.5% up from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Equity Average is $10.9 million, which was up 64528.82% from $8.6 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Equity Average ranged from a high of $16.6 million in Q1 2022 and a low of -$2.0 million during Q3 2024
  • Its 5-year average for Equity Average is $4.8 million, with a median of $2.5 million in 2023.
  • Its Equity Average has fluctuated over the past 5 years, first tumbled by 35100.83% in 2024, then soared by 471000.0% in 2025.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Equity Average stood at $11.5 million in 2021, then crashed by 54.93% to $5.2 million in 2022, then crashed by 108.83% to -$459500.0 in 2023, then plummeted by 242.76% to -$1.6 million in 2024, then surged by 790.7% to $10.9 million in 2025.
  • Its Equity Average stands at $10.9 million for Q3 2025, versus $8.6 million for Q2 2025 and $2.4 million for Q1 2025.